Enfuvirtide approved for defusing HIV

By Burton A.  

The Lancet Infectious Diseases, Vol. 3, Iss. 5, 2003-05 ,pp. : 260-260

Elsevier

Access to resources Recommend Favorite

Priority Strategies for Sustainable Fight Against HIV/AIDS in Low-Income Countries

By  

Current HIV Research, Vol. 2, Iss. 4, 2004-10 ,pp. : 377-393

Bentham Science Publishers

Access to resources Recommend Favorite

Investigating the interface between health system reform and HIV/AIDS in sub-Saharan Africa: an approach for improving the fight against the epidemic

By Dawes Rasmus C  

African Journal of AIDS Research, Vol. 2, Iss. 1, 2003-05 ,pp. : 23-31

Routledge Ltd

Access to resources Recommend Favorite

Influence of subcutaneous injection site on the steady-state pharmacokinetics of enfuvirtide (T-20) in HIV-1-infected patients

By Lalezari J.P.   Patel I.H.   Zhang X.   Dorr A.   Hawker N.   Siddique Z.   Kolis S.J.   Kinchelow T.  

Journal of Clinical Virology, Vol. 28, Iss. 2, 2003-10 ,pp. : 217-222

Elsevier

Access to resources Recommend Favorite

Support groups for HIV-positive people in South Africa: Who joins, who does not, and why?

By  

African Journal of AIDS Research, Vol. 13, Iss. 1, 2014-01 ,pp. : 1-11

Routledge Ltd

Access to resources Recommend Favorite